Cornerstone Advisors (Washington)’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Cornerstone Advisors (Washington)'s NVS Position: Q3 2019 in Review
Cornerstone Advisors (Washington) sold out of Novartis (NVS) in Q3 2019, closing a stake of 1,405 shares — an estimated $128K sold.
Cornerstone Advisors (Washington) first reported a position in NVS in Q2 2013 and held it in 25 quarters. The position peaked at $128K in Q2 2019. 1,091 funds tracked by Wall St. Rank hold NVS as of Q3 2019.
- Cornerstone Advisors (Washington) reported no remaining Novartis position as of Q3 2019 after selling out during the quarter.
- Cornerstone Advisors (Washington) sold 1,405 Novartis shares in Q3 2019, an estimated $128K.
- Cornerstone Advisors (Washington) first reported a position in Novartis in Q2 2013 and held it in 25 quarters.
- Cornerstone Advisors (Washington)'s Novartis position peaked at $128K in Q2 2019.
- 1,091 funds tracked by Wall St. Rank held Novartis as of Q3 2019.
Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.